Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).
J Clin Oncol
; 36(25): 2593-2602, 2018 09 01.
Article
en En
| MEDLINE
| ID: mdl-29975624
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Linfoma de Células B Grandes Difuso
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
J Clin Oncol
Año:
2018
Tipo del documento:
Article